Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Asset Utilization Ratio: 2018-2025

Historic Asset Utilization Ratio for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to 0.23.

  • Arcus Biosciences' Asset Utilization Ratio rose 11.34% to 0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23, marking a year-over-year increase of 11.34%. This contributed to the annual value of 0.23 for FY2024, which is 135.25% up from last year.
  • Latest data reveals that Arcus Biosciences reported Asset Utilization Ratio of 0.23 as of Q3 2025, which was down 0.26% from 0.23 recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Asset Utilization Ratio peaked at 0.32 during Q4 2021, and registered a low of 0.04 during Q3 2021.
  • For the 3-year period, Arcus Biosciences' Asset Utilization Ratio averaged around 0.16, with its median value being 0.20 (2024).
  • Examining YoY changes over the last 5 years, Arcus Biosciences' Asset Utilization Ratio showed a top increase of 591.67% in 2022 and a maximum decrease of 73.61% in 2022.
  • Arcus Biosciences' Asset Utilization Ratio (Quarterly) stood at 0.32 in 2021, then tumbled by 73.61% to 0.08 in 2022, then rose by 23.10% to 0.10 in 2023, then surged by 105.75% to 0.21 in 2024, then climbed by 11.34% to 0.23 in 2025.
  • Its Asset Utilization Ratio was 0.23 in Q3 2025, compared to 0.23 in Q2 2025 and 0.12 in Q1 2025.